Moderna Jumps 10% on Hantavirus Vaccine Push as Cruise Ship Outbreak Revives mRNA Hopes
Markets Daniel Marsh

Moderna Jumps 10% on Hantavirus Vaccine Push as Cruise Ship Outbreak Revives mRNA Hopes

Moderna shares rose 10% on Friday after the company revealed early-stage work on a hantavirus vaccine, spurred by a deadly Andes virus outbreak on the MV Hondius cruise ship.

MRNA GSK
Wynn Resorts Shares Slide on UAE Delay and $900M Macau Expansion
Markets Daniel Marsh

Wynn Resorts Shares Slide on UAE Delay and $900M Macau Expansion

Wynn Resorts stock dropped 6.7% Friday despite beating Q1 profit estimates, as a delayed UAE opening and a $900M+ Macau expansion raised capital concerns.

WYNN LVS MGM
MaxLinear Stock Surges Past $100 on AI Data Center Demand Ahead of Key Vote
Technology Sarah Chen

MaxLinear Stock Surges Past $100 on AI Data Center Demand Ahead of Key Vote

MaxLinear shares surged over 21% to $101.20, driven by AI demand. A shareholder vote on expanding the equity plan is set for May 20.

MXL
Arbor Realty Trust Plunges After Dividend Cut and Weak Q1 Results
Markets Daniel Marsh

Arbor Realty Trust Plunges After Dividend Cut and Weak Q1 Results

Arbor Realty Trust cut its dividend to $0.17 and reported Q1 net income of just $629,000, sending shares down 11% as investors focus on troubled loans.

Intel Stock Hits Record on Apple Chip Deal Speculation, TSMC Faces Heat
Technology Sarah Chen

Intel Stock Hits Record on Apple Chip Deal Speculation, TSMC Faces Heat

Intel shares hit a record high following a report of a preliminary deal with Apple for chip manufacturing, while Apple explores alternatives to TSMC.

INTC AAPL TSM NVDA AMD
Novavax Shares Surge on Pfizer Deal, Vaccine Strategy Shift
Markets Daniel Marsh

Novavax Shares Surge on Pfizer Deal, Vaccine Strategy Shift

Novavax shares surged 13% Friday after Q1 revenue of $139.5 million beat estimates, fueled by a $30 million Pfizer licensing deal for Matrix-M adjuvant.

NVAX PFE SNY MRNA
POET Technologies Stock Rebounds Amid Securities Lawsuit and Marvell Fallout
Markets Daniel Marsh

POET Technologies Stock Rebounds Amid Securities Lawsuit and Marvell Fallout

POET Technologies shares rebounded 14.5% to $10.97 on Friday, even as a securities lawsuit over tax disclosures and cancelled Celestial AI orders moves forward with a June 29 lead plaintiff deadline.

POET MRVL AVGO NVDA
nLIGHT Soars on Record Defense Revenue, 55% Sales Jump
Earnings James Calloway

nLIGHT Soars on Record Defense Revenue, 55% Sales Jump

nLIGHT shares surged 10.3% after Q1 revenue jumped 55% to $80.2M, driven by record aerospace and defense sales, with the company swinging to a profit and launching its HADES laser system.

LASR
Traws Pharma Soars on Hantavirus Push After Cruise Fatalities
Markets Daniel Marsh

Traws Pharma Soars on Hantavirus Push After Cruise Fatalities

Traws Pharma shares surged over 21% after the biotech said it would advance hantavirus drug candidates following a fatal cruise ship outbreak. The company has no approved treatments and recently raised $10 million.

TRAW
Sandisk Rebounds as AI Memory Supply Tightness Drives Demand
Technology Sarah Chen

Sandisk Rebounds as AI Memory Supply Tightness Drives Demand

Sandisk shares surged 11.7% to $1,497 on Friday, rebounding from a drop, as AI memory supply tightness and $42 billion in future contracts boost investor confidence.

SNDK MU
Opendoor Shares Slide as Q1 Loss Widens Despite Revenue Beat
Earnings James Calloway

Opendoor Shares Slide as Q1 Loss Widens Despite Revenue Beat

Opendoor Technologies shares dropped 4.5% following a first-quarter net loss of $173 million, wider than last year, though revenue of $720 million beat analyst estimates. The company doubled acquisition contracts but sold fewer homes.

OPEN
Eos Energy Shares Surge 22% Ahead of Earnings on AI Data Center Deal
Markets Daniel Marsh

Eos Energy Shares Surge 22% Ahead of Earnings on AI Data Center Deal

Eos Energy shares surged 22% to $7.75 ahead of its May 13 earnings report, fueled by a joint development deal with TURBINE-X Energy for AI data center storage. Investors eye manufacturing rebound and legal hurdles.

EOSE